Innovation and integration Unite. Siemens Molecular CT takes the lead in the evolution of diagnostic imaging | Nuclear Molecular
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Communities Nuclear/Molecular Innovation and integration Unite. Siemens Molecular CT takes the lead in the evolution of diagnostic imaging

Innovation and integration Unite. Siemens Molecular CT takes the lead in the evolution of diagnostic imaging

Communities
Siemens Healthcare has introduced its Biograph mCT at the European Association of Nuclear Medicine conference in Munich, Germany.

Continuing its leadership in molecular imaging innovation, Siemens Healthcare (www.siemens.com/healthcare) introduces Biograph mCT at the European Association of Nuclear Medicine conference in Munich, Germany. Biograph mCT is the only integrated imaging device to offer routine, whole-body PET scanning in just five minutes, and enables both molecular imaging and radiology to take advantage of its large bore capacity, ultra high-definition technology, combining HD-PET and time-of-flight, and advanced CT capabilities with up to 128 slices, a first in integrated imaging.

"Siemens is pleased to offer a powerful new platform in integrated imaging today," said Michael Reitermann, chief executive officer, Molecular Imaging, Siemens Healthcare. "For institutions looking for cutting-edge technology, the greatest level of patient care and maximum return on investment, Biograph mCT offers the complete solution: PET with unlimited CT capabilities, CT with “molecular resolution," and all of a customer's molecular imaging and radiology needs in one system."

Biograph mCT with ultra HD·PET technology is the world's only PET system that offers 2 mm uniform resolution throughout the field of view (FOV), coupled with enhanced contrast with reduced noise, compared to standard PET acquisitions because of the addition of time-of-flight (TOF) technology. Measuring the time difference between photon detection and better localizing the coincidence origins enables more accurate lesion depiction. Siemens TrueV extended field of view (FOV) technology enables 70 percent more counts with 30 percent less bed positions. Biograph mCT can achieve an unprecedented five-minute PET acquisition time by leveraging the combination of ultraHD·PET technology and TrueV extended FOV.

Ultra HD for increased clinical performance

Researchers from the University of Utah in Salt Lake City presented on the value of TOF PET technology when used with advanced reconstruction algorithms, such as HD·PET in producing faster images with better diagnostic results for practitioners. They concluded that the resulting data produced higher-quality images with less “noise” than conventional PET technology. The study also found that the combined methods resulted in a marked improvement in detecting cancerous tumors when evaluated at several milestones during PET image reconstruction.

“Our research adds to the growing number of studies that indicate reconstruction methods, such as HD-PET and TOF, have the potential to significantly improve physicians’ abilities to accurately diagnose and treat cancer,” said Dan Kadrmas, PhD, a professor in the department of Radiology at the University of Utah in Salt Lake City and lead researcher for the study, Impact of TOF on PET Tumor Detection. “While traditional PET scanners offer several advances over other types of diagnostic tools, these advanced systems could take those advantages to a whole new level.” Kadrmas and his team presented the study at the Society of Nuclear Medicine conference in June.

 

Related Articles